multivalent influenza vaccine (mannatide adjuvant) (Shanxi Maike Aote Technology/GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemultivalent influenza vaccine (mannatide adjuvant) (Shanxi Maike Aote Technology/GlaxoSmithKline)
Drug Alias Namemultivalent influenza vaccine (mannatide adjuvant) (Shanxi Maike Aote Technology/Zhejiang Tianyuan Bio-Pharmaceutical)multivalent influenza vaccine (mannatide adjuvant) (Xi'an Jiaotong University)
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesXi'An Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShaanxi Micot Pharmaceutical Technology Co LtdXi'An Jiaotong UniversityGlaxosmithkline Plc +[4] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A